Last reviewed · How we verify
NCT04645329
Immobilization in Reverse Shoulder Prosthesis
NA trial testing shoulder immovilization sling in Rotator Cuff Tear Arthropathy in 50 participants. Status unknown.
30 April 2022
Quick facts
| Lead sponsor | Hospital del Mar |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 January 2020 |
| Primary completion | 30 April 2022 |
| Estimated completion | 30 April 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- shoulder immovilization sling
Conditions studied
- Rotator Cuff Tear Arthropathy — all drugs for Rotator Cuff Tear Arthropathy →
Sponsor
Hospital del Mar
Who can join
Adults 65 to 85, any sex, with Rotator Cuff Tear Arthropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Reverse shoulder prostheses are the treatment of choice in elderly patients with rotator cuff arthropathy. Traditionally these patients have been immobilized for 3 weeks in the immediate postoperative period in order to have good pain control. However, there are no studies that determine the most appropriate period of immobilization. In fact, patients undergoing this type of surgery begin rehabilitation exercises within 24 hours of surgery without experiencing increased pain or requiring specific analgesic treatment. There is a demand in the elderly to limit immobilization time as much as possible, as some live alone and need to be self-sufficient and others have dependents. It would be good to know if it is really necessary to make an immobilization in these patients undergoing this type of surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04645329
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rotator Cuff Tear Arthropathy
Currently open trials in the same condition.
- NCT07255534 — Efficacy and Safety of Digital Therapeutics for Improving Shoulder Function After Rotator Cuff Repair · NA · recruiting
- NCT05439850 — Bioinductive Patch for Full-Thickness Rotator Cuff Tears · Phase 4 · recruiting
- NCT05067543 — Perform Humeral System Study · recruiting
- NCT05002335 — Clinical and Radiological Outcomes of Medacta Shoulder System (BE) · active not recruiting
- NCT04529798 — Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless · recruiting
Other Hospital del Mar trials
Trials by the same sponsor.
- NCT07481760 — Acute Cholecystitis Biliary Complications - ICG · NA · not yet recruiting
- NCT07208994 — Pathways to Equitable Access to Kidney Transplantation in Spain: A Transformative Mixed-methods Study Protocol · not yet recruiting
- NCT06981273 — Robotic vs Open Pancreatoduodenectomy · NA · not yet recruiting
- NCT06765044 — Textbook Outcomes in Urgent Appendectomy · not yet recruiting
- NCT06228027 — External Validation os the ACME Scoring System · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04645329 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital del Mar
- Last refreshed: 31 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04645329.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing